[1] Vaishnavi, C., Bhasin, D.K., Kochhar, R. and Singh, K. (2000) Clostridium difficile Toxin and Faecal Lactoferrin Assays in Adult Patients. Microbes and Infection, 2, 1827-1830.
http://dx.doi.org/10.1016/S1286-4579(00)01343-5
[2] Burke, K.E. and Lamont, J.T. (2014) Clostridium difficile Infection: A Worldwide Disease. Gut and Liver, 8, 1-6.
http://dx.doi.org/10.5009/gnl.2014.8.1.1
[3] Jalali, M., Khorvash, F., Warriner, K. and Weese, J.S. (2012) Clostridium difficile Infection in an Iranian Hospital. BMC Research Notes, 5, 159.
http://dx.doi.org/10.1186/1756-0500-5-159
[4] Zar, F.A., Bakkanagari, S.R., Moorthi, K.M. and Davis, M.B. (2007) A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity. Clinical Infectious Diseases, 45, 302-307.
http://dx.doi.org/10.1086/519265
[5] Barbut, F., Delmee, M., Brazier, J.S., Petit, J.C., Poxton, I.R., Rupnik, M., Lalande, V., Schneider, C., Mastrantonio, P., Alonso, R., Kuipjer, E., Tvede, M. and The ESCMID Study Group on Clostridium difficile (ESGCD) (2003) A European Survey of Diagnostic Methods and Testing Protocols for Clostridium difficile. Clinical Microbiology and Infection, 9, 989-996.
http://dx.doi.org/10.1046/j.1469-0691.2003.00683.x
[6] Arroyo, L.G., Rousseau, J., Willey, B.M., Low, D.E., Staempfli, H., McGeer, A. and Weese, J.S. (2005) Use of a Selective Enrichment Broth to Recover Clostridium difficile from Stool Swabs Stored under Different Conditions. Journal of Clinical Microbiology, 43, 5341-5343.
http://dx.doi.org/10.1128/JCM.43.10.5341-5343.2005
[7] George, W.L., Sutter, V.L., Citron, D. and Finegold, S.M. (1979) Selective and Differential Medium for Isolation of Clostridium difficile. Journal of Clinical Microbiology, 9, 214-219.
[8] Perry, J.D., Asir, K., Halimi, D., Orenga, S., Dale, J., Payne, M., Carlton, R., Evans, J. and Gould, F.K. (2010) Evaluation of a Chromogenic Culture Medium for Isolation of Clostridium difficile within 24 Hours. Journal of Clinical Microbiology, 48, 3852-3858.
http://dx.doi.org/10.1128/JCM.01288-10
[9] Wilcox, M.H., Fawley, W.N. and Parnell, P. (2000) Value of Lysozyme Agar Incorporation and Alkaline Thioglycollate Exposure for the Environmental Recovery of Clostridium difficile. Journal of Hospital Infection, 44, 65-69.
http://dx.doi.org/10.1053/jhin.1999.0253
[10] Wren, M. (2010) Clostridium difficile Isolation and Culture Techniques Methods. Journal of Molecular Biology, 646, 39-52.
http://dx.doi.org/10.1007/978-1-60327-365-7_3
[11] Drudy, D., Kyne, L., O’Mahony, R. and Fanning, S. (2007) GyrA Mutations in Fluoroquinolone-Resistant Clostridium difficile PCR-027. Emerging Infectious Diseases, 13, 504-505.
http://dx.doi.org/10.3201/eid1303.060771
[12] Muto, C.A., Pokrywka, M., Shutt, K., Mendelsohn, A.B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystofiak, S., Patel-Brown, S., Pasculle, A.W., Paterson, D.L., Saul, M. and Harrison, L.H. (2005) A Large Outbreak of Clostridium difficile-Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use. Infection Control and Hospital Epidemiology, 26, 273-280.
http://dx.doi.org/10.1086/502539
[13] Drudy, D., Quinn, T., O’Mahony, R., Kyne, L., O’Gaora, P. and Fanning, S. (2006) High-Level Resistance to Moxifloxacin and Gatifloxacin Associated with a Novel Mutation in GyrB in Toxin-A-Negative, Toxin-B-Positive Clostridium difficile. Journal of Antimicrobial Chemotherapy, 58, 1264-1267.
http://dx.doi.org/10.1093/jac/dkl398
[14] Poilane, I., Cruaud, P., Torlotin, J.C. and Collignon, A. (2000) Comparison of the E-Test to the Reference Agar Dilution Method for Antibiotic Susceptibility Testing of Clostridium difficile. Clinical Microbiology and Infection, 6, 155-156.
http://dx.doi.org/10.1046/j.1469-0691.2000.00034-4.x
[15] Kuijper, E.J., Barbut, F., Brazier, J.S., Kleinkauf, N., Eckmanns, T., Lambert, M.L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D.J., Coia, J.E., Pituch, H., Reichert, P., Even, J., Mossong, J., Widmer, A.F., Olsen, K.E., Allerberger, F., Notermans, D.W., Delmée, M., Coignard, B., Wilcox, M., Patel, B., Frei, R., Nagy, E., Bouza, E., Marin, M., Akerlund, T., Virolainen-Julkunen, A., Lyytikainen, O., Kotila, S., Ingebretsen, A., Smyth, B., Rooney, P., Poxton, I.R. and Monnet, D.L. (2008) Update of Clostridium difficile Infection Due to PCR Ribotype 027 in Europe 2008. Euro Surveillance, 13, Article ID: 18942.
[16] Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., Pepin, J. and Wilcox, M.H., Society for Healthcare Epidemiology of America and Infectious Diseases Society of America (2010) Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology, 31, 431-455.
http://dx.doi.org/10.1086/651706
[17] Lee, K., Yong, D., Yum, J., Sohn, Y.S. and Chong, Y. (2000) Modification of Cycloserine Cefoxitin Fructose Agar to Suppress Growth of Yeasts from Stool Specimens. Anaerobe, 6, 269-271.
http://dx.doi.org/10.1006/anae.2000.0355
[18] Gupta, U. and Yadav, R.N. (1985) Clostridium difficile in Hospital Patients. Indian Journal of Medical Research, 82, 398-401.
[19] Ayyagari, A., Sharma, P., Venkateswarlu, Mehta, S. and Agarwal, K.C. (1986) Prevalence of Clostridium difficile in Pseudomembranous and Antibiotic Associated Colitis in North India. Journal of Diarrhoeal Diseases Research, 4, 157-160.
[20] Niyogi, S.K., Dutta, P., Dutta, D., Mitra, U. and Sikdar, S. (1991) Clostridium difficile and Its Cytotoxin in Hospitalized Children with Acute Diarrhea. Indian Pediatrics, 28, 1129-1132.
[21] Dutta, P., Niyogi, S.K., Mitra, U., Rasaily, R., Bhattacharya, M.K., Chakraborty, S. and Mitra, A. (1994) Clostridium difficile in Antibiotic Associated Pediatric Diarrhea. Indian Pediatrics, 31, 121-126.
[22] Gogate, A., De, A., Nanivadekar, R., Mathur, M., Saraswathi, K., Jog, A. and Kulkarni, M.V. (2005) Diagnostic Role of Stool Culture and Toxin Detection in Antibiotic Associated Diarrhoea Due to Clostridium difficile in Children. Indian Journal of Medical Research, 122, 518-524.
[23] Dhawan, B., Chaudhry, R. and Sharma, N. (1999) Incidence of Clostridium difficile Infection: A Prospective Study in an Indian Hospital. Journal of Hospital Infection, 43, 275-280.
http://dx.doi.org/10.1016/S0195-6701(99)90423-1
[24] Vaishnavi, C., Kochhar, R., Bhasin, D.K., Thapa, B.R. and Singh, K. (1999) Detection of Clostridium difficile Toxin by an Indigenously Developed Latex Agglutination Assay. Tropical Gastroenterology, 22, 33-35.
[25] Vaishnavi, C., Thapa, B.R., Thennarasu, K. and Singh, K. (2002) Faecal Lactoferrin Assay as an Adjunct to Clostridium difficile Diarrhea. Indian Journal of Pathology and Microbiology, 45, 69-73.
[26] Vishwanath, S., Singhal, A., D’Souza, A., Mukhopadhyay, C., Varma, M. and Bairy, I. (2013) Clostridium difficile Infection at a Tertiary Care Hospital in South India. Journal of the Association of Physicians of India, 61, 804-806.
[27] Holloway, K.A. (2011) Promoting the Rational Use of Antibiotics, Regional Health Forum WHO South East Asia Region. Volume 15, 122-130.
[28] Austin, D.J. and Anderson, R.M. (1999) Transmission Dynamics of Epidemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in England and Wales. Journal of Infectious Diseases, 179, 883-891.
http://dx.doi.org/10.1086/314682
[29] Cocanour, C.S. (2005) Best Strategies in Recurrent or Persistent Clostridium difficile Infection. Surgical Infections, 12, 235-239.
http://dx.doi.org/10.1089/sur.2010.080
[30] Dong, D., Zhang, L., Chen, X., Jiang, C., Yu, B., Wang, X. and Peng, Y. (2013) Antimicrobial Susceptibility and Resistance Mechanisms of Clinical Clostridium difficile from a Chinese Tertiary Hospital. International Journal of Antimicrobial Agents, 41, 80-84.
http://dx.doi.org/10.1016/j.ijantimicag.2012.08.011
[31] Goudarzi, M., Goudarzi, H., Alebouyeh, M., Rad, M.A., Mehr, F.S.S., Mohammad, R.Z. and Mohammad, M.A. (2013) Antimicrobial Susceptibility of Clostridium difficile Clinical Isolates in Iran. Iranian Red Crescent Medical Journal, 15, 704-711.
http://dx.doi.org/10.5812/ircmj.5189
[32] Vecchio, A.L. and Zacur, G.M. (2012) Clostridium difficile Infection: An Update on Epidemiology, Risk Factors and Therapeutic Options. Current Opinion in Gastroenterology, 28, 1-9.
http://dx.doi.org/10.1097/MOG.0b013e32834bc9a9
[33] Sebaihia, M., Wren, B.W., Mullany, P., Fairweather, N.F., Minton, N., Stabler, R., Thomson, N.R., Roberts, A.P., Cerdeno-Tárraga, A.M., Wang, H., Holden, M.T., Wright, A., Churcher, C., Quail, M.A., Baker, S., Bason, N., Brooks, K., Chillingworth, T., Cronin, A., Davis, P., Dowd, L., Fraser, A., Feltwell, T., Hance, Z., Holroyd, S., Jagels, K., Moule, S., Mungall, K., Price, C., Rabbinowitsch, E., Sharp, S., Simmonds, M., Stevens, K., Unwin, L., Whithead, S., Dupuy, B., Dougan, G., Barrell, B. and Parkhill, J. (2006) The Multidrug-Resistant Human Pathogen Clostridium difficile Has a Highly Mobile, Mosaic Genome. Nature Genetics, 38, 779-786.
http://dx.doi.org/10.1038/ng1830
[34] Spigaglia, P., Barbanti, F. and Mastrantonio, P. (2011) Multidrug Resistance in European Clostridium difficile Clinical Isolates. Journal of Antimicrobial Chemotherapy, 66, 2227-2234.
http://dx.doi.org/10.1093/jac/dkr292
[35] Brazier, J.S. (2001) Typing of Clostridium difficile. Clinical Microbiology and Infection, 7, 428-431.
http://dx.doi.org/10.1046/j.1198-743x.2001.00288.x
[36] Chong, P.M., Lynch, T., McCorrister, S., Kibsey, P., Miller, M., Gravel, D., Westmacott, G.R. and Mulvey, M.R., The Canadian Nosocomial Infection Surveillance Program (CNISP) (2014) Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole. PLoS ONE, 9, e82622.
http://dx.doi.org/10.1371/journal.pone.0082622
[37] Peláez, T., Alcalá, L., Alonso, R., Rodriguez-Creixems, M., García-Lechuz, J. and Bouza, E. (2002) Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin. Antimicrobial Agents and Chemotherapy, 46, 1647-1650.
http://dx.doi.org/10.1128/AAC.46.6.1647-1650.2002
[38] Fernandez, A., Anand, G. and Friedenberg, F. (2004) Factors Associated with Failure of Metronidazole in Clostridium difficile-Associated Disease. Journal of Clinical Gastroenterology, 38, 414-418.
http://dx.doi.org/10.1097/00004836-200405000-00005
[39] Peláez, T., Cercenado, E., Alcalá, L., Marín, M., Martin-Lopez, A., Martínez-Alarcón, J., Catalán, P., Sánchez-Somolinos, M. and Bouza, E. (2008) Metronidazole Resistance in Clostridium difficile Is Heterogeneous. Journal of Clinical Microbiology, 46, 3028-3032.
http://dx.doi.org/10.1128/JCM.00524-08
[40] McFarland, L.V. (2005) Alternative Treatments for Clostridium difficile Disease: What Really Works? Journal of Medical Microbiology, 54, 101-111.
http://dx.doi.org/10.1099/jmm.0.45753-0
[41] Pépin, J., Valiquette, L., Gagnon, S., Routhier, S. and Brazeau, I. (2007) Outcomes of Clostridium difficile-Associated Disease Treated with Metronidazole or Vancomycin before and after the Emergence of NAP1/027. The American Journal of Gastroenterology, 102, 2781-2788.
http://dx.doi.org/10.1111/j.1572-0241.2007.01539.x
[42] Huang, H., Fang, H., Weintraub, A. and Nord, C.E. (2009) Distinct Ribotypes and Rates of Antimicrobial Drug Resistance in Clostridium difficile from Shanghai and Stockholm. Clinical Microbiology and Infection, 15, 1170-1173.
http://dx.doi.org/10.1111/j.1469-0691.2009.02992.x
[43] Spigaglia, P. and Mastrantonio, P. (2004) Comparative Analysis of Clostridium difficile Clinical Isolates Belonging to Different Genetic Lineages and Time Periods. Journal of Medical Microbiology, 53, 1129-1136.
http://dx.doi.org/10.1099/jmm.0.45682-0
[44] Tenover, F.C., Tickler, I.A. and Persing, D.H. (2012) Antimicrobial-Resistant Strains of Clostridium difficile from North America. Antimicrobial Agents and Chemotherapy, 56, 2929-2932.
[45] Collins, D.A., Hawkey, P.M. and Riley, T.V. (2013) Epidemiology of Clostridium difficile Infection in Asia. Antimicrobial Resistance and Infection Control, 2, 21.
http://dx.doi.org/10.1186/2047-2994-2-21
[46] Borgmann, S., Jakobiak, T., Gruber, H., Reil, M., Schroder, H., Kist, M. and Sagel, U. (2010) Association of Ciprofloxacin Prescriptions to Outpatients to Clostridium difficile Infections. Euro Surveillance, 15, Article ID: 19479.
[47] Gerding, D.N. (2004) Clindamycin, Cephalosporins, Fluoroquinolones, and Clostridium difficile-Associated Diarrhea: This Is an Antimicrobial Resistance Problem. Clinical Infectious Diseases, 38, 646-648.
http://dx.doi.org/10.1086/382084
[48] Loo, V.G., Poirier, L., Miller, M.A., Oughton, M., Libman, M.D., Michaud, S., Bourgault, A.M., Nguyen, T., Frenette, C., Kelly, M., Vibien, A., Brasssard, P., Fenn, S., Dewar, K., Hudson, T.J., Horn, R., René, P., Monczak, Y. and Dascal, A. (2005) A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile Associated Diarrhea with High Morbidity and Mortality. New England Journal of Medicine, 353, 2442-2449.
http://dx.doi.org/10.1056/NEJMoa051639
[49] Drudy, D., Goorhuis, B., Bakker, D., Kyne, L., van den Berg, R., Fenelon, L., Fanning, S. and Kuijper, E.J. (2008) Clindamycin-Resistant Clone of Clostridium difficile PCR Ribotype 027, Europe. Emerging Infectious Diseases, 14, 1485-1487.
http://dx.doi.org/10.3201/eid1409.071346
[50] Mooyottu, S., Flock, G., Kollanoor-Johny, A., Upadhyaya, I., Jayarao, B.A. and Venkitanarayanan, K. (2005) Characterization of a Multidrug Resistant Clostridium difficile Meat Isolate. International Journal of Food Microbiology, 192, 111-116.
http://dx.doi.org/10.1016/j.ijfoodmicro.2014.10.002